Projects funded by the NCN
Oral endoglin based-DNA vaccine combined with gene encoding IL-12 can polarize tumor microenvironment from proangiogenic and immunosuppressive phenotype to antiangiogenic and immunostimulatory
2013/11/B/NZ4/04468
Keywords:
Antiangiogenic vaccine IL-12 tumor associated macrophages (TAM) normalization of tumor vasculature vessel perfusion macrophage phenotype polarization
Descriptors:
- NZ4_12: Other related subjects
- NZ6_1: Adaptive and innate immunity
Panel:
NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution :
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 9
Call: OPUS 6 - announced on 2013-09-16
Amount awarded: 599 410 PLN
Project start date (Y-m-d): 2014-07-11
Project end date (Y-m-d): 2017-07-10
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled